George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Pin to quick picksPATH.L Regulatory News (PATH)

  • There is currently no data for PATH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Further re the Acquisition of DT Ultravert

1 Oct 2020 11:41

RNS Number : 8244A
Path Investments plc
01 October 2020
 

Path Investments plc

("Path" or the "Company")

 

Further re the Acquisition of DT Ultravert

 

Acquisition of remaining 25% of DT Ultravert from Diversion Technologies LLC

 

Update on Acquisition of 75% of DT Ultravert and Kansas Land Leases from Zoetic International plc

 

 

Path Investments plc (TIDM: PATH), the energy and natural resources investment company, is pleased to announce certain updates regarding the Company's proposed acquisition of the patented proprietary technology, DT Ultravert ("DTU").

 

Acquisition of 25% of DT Ultravert from Diversion Technologies LLC

 

The Company is pleased to announce that it has entered into a binding agreement with Diversion Technologies LLC ("DTL") to acquire its 25% ownership of DTU, together with all associated applications and trademarks (the "Transaction").

 

The consideration for the Transaction will be satisfied by the issue by Path to DTL of 10,000,000 new ordinary shares in the Company, together with 5,000,000 warrants to subscribe for ordinary shares in Path at any time following completion at an exercise price of 1.5 pence per share.

 

Completion of the Transaction is subject to the publication of a prospectus by Path prepared in accordance with the Prospectus Regulation Rules made under section 73A of the Financial Services and Markets Act 2000 (as amended) and approved by the UK Financial Conduct Authority under section 87A of Financial Services and Markets Act 2000 (as amended) and readmission of Path's ordinary shares to the standard segment of the Official List maintained by the Financial Conduct Authority, and readmission to trading on the Main Market of the London Stock Exchange.

 

Update on the Acquisition of 75% of DT Ultravert and the Kansas Land Leases from Zoetic International plc

 

With the announcement today of our conditional acquisition of the remaining 25% of DTU, Path is pleased to reiterate its binding agreement with Zoetic International plc ("Zoetic").

 

The consideration for the acquisition of the other 75% of DT Ultravert and the Kansas Land Leases will be satisfied by the issue by Path to Zoetic of 15,000,000 warrants to subscribe for ordinary shares in Path at any time from the first to the third anniversaries following completion at an exercise price of 0.75 pence per share, together with 15,000,000 warrants to subscribe for ordinary shares in Path at any time from the first to the third anniversaries following completion at an exercise price of 1.5 pence per share.

 

Additionally, Path has agreed to pay, in perpetuity, to Zoetic a royalty equal to 6% of all gross revenues derived from its former 75% holding in DTU, accruing from receipt of first revenues, although not payable until 12 months thereafter. Royalty payments will be settled quarterly, with payments being made at the end of the quarter in which Path earns revenue. For the avoidance of doubt, Path has no obligation to make a payment to Zoetic unless it has received the revenue payment from its own customers.

 

Royalty payments due until the fifth anniversary of completion, at Path's discretion, may be settled as to 50 per cent. by the issue of new ordinary shares in Path, in which case the value of those ordinary shares will be based on the volume weighted average price over the 10 business days prior to the date of issue. Thereafter payments due will be settled in cash.

 

Zoetic will enter into an orderly marketing agreement in respect of the new ordinary shares of Path issued as consideration and any exercise of warrants for a period of 12 months from the date of completion.

 

Completion of the acquisition from Zoetic is subject to a number of items, including the publication of a prospectus by Path prepared in accordance with the Prospectus Regulation Rules made under section 73A of the Financial Services and Markets Act 2000 (as amended) and approved by the UK Financial Conduct Authority under section 87A of Financial Services and Markets Act 2000 (as amended) and readmission of Path's ordinary shares to the standard segment of the Official List maintained by the Financial Conduct Authority, and readmission to trading on the Main Market of the London Stock Exchange.

 

Commenting, Christopher Theis CEO of Path, said: "We are delighted to have agreed the acquisition of the remaining 25% of DTU, together with all associated applications and trademarks from Diversion Technologies LLC. Together with our acquisition of the 75% holding by Zoetic International plc, announced on 27 May 2020, this important transaction brings into our ownership 100% of the DTU technology.

 

"We are excited by the opportunities that 100% ownership of the technology brings to Path, and we believe we are well positioned to be able to exploit this exciting technology to ensure that its commercial benefits are maximised. As a re-fracking well stimulation and protection technology, DTU is a potentially more effective and cheaper method to stimulate and protect conventional and unconventional formations, together with providing environmental benefits."

 

 

For further information please contact:

Path Investments plc

C/O IFC

Christopher Theis

IFC Advisory Limited (Financial PR & IR)

020 3934 6630

Tim Metcalfe

Zach Cohen

Grant Thornton UK LLP (Financial Adviser)

Samantha Harrison

020 7865 2411

Harrison Clarke

020 7184 4384

Keith, Bayley, Rogers & Co. Limited (Broker)

Brinsley Holman

07776 30 22 28

Graham Atthill-Beck

07506 43 41 07

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQKKDBQKBDDKKK
Date   Source Headline
7th Apr 20227:00 amRNSUpdate on Acquisition
5th Apr 20227:00 amRNSInvestor Presentation
1st Apr 20222:45 pmRNSResult of General Meeting
14th Mar 20221:09 pmRNSPublication of Prospectus, Notice of GM, Fundraise
1st Feb 20227:00 amRNSProposed Transaction Update
31st Dec 20217:00 amRNSProposed Transaction Update
18th Nov 20217:00 amRNSAppointment of Joint Broker
26th Oct 20217:00 amRNSProposed Transaction Update
13th Oct 20216:02 pmRNSCorrection: Holding(s) in Company
13th Oct 20214:52 pmRNSHolding(s) in Company
11th Oct 20217:00 amRNSBlock listing Interim Review
29th Sep 20217:00 amRNSInterim Results for the six months to 30 June 2021
28th Sep 20212:45 pmRNSResult of AGM
22nd Sep 20212:41 pmRNSFurther secured loan provided to DG Innovate
9th Sep 20216:01 pmRNSHolding(s) in Company
2nd Sep 20217:00 amRNSNotice of AGM
18th Aug 202111:54 amRNSCorrection: Holding(s) in Company
18th Aug 20217:00 amRNSHolding(s) in Company
13th Aug 20217:45 amRNSProposed Acquisition of DG Innovate & Suspension
14th Jul 20215:23 pmRNSHolding(s) in Company
14th Jul 20212:39 pmRNSHolding(s) in Company
24th Jun 20217:00 amRNSFinal Results for the Year Ended 31 December 2020
16th Jun 20217:00 amRNSHolding(s) in Company
8th Jun 202111:49 amRNSHolding(s) in Company
7th Jun 202112:04 pmRNSHolding(s) in Company
9th Apr 202110:03 amRNSHolding(s) in Company
9th Apr 20217:00 amRNSBlock Listing
1st Apr 20215:02 pmRNSHolding(s) in Company
31st Mar 20219:55 amRNSTotal Voting Rights
24th Mar 20212:06 pmRNSDirector/PDMR Share Transaction
19th Mar 20218:53 amRNSHolding(s) in Company
12th Mar 20215:36 pmRNSAdmission of previously issued shares
12th Mar 202112:50 pmRNSPublication of Prospectus
8th Mar 202111:05 amRNSSecond Price Monitoring Extn
8th Mar 202111:00 amRNSPrice Monitoring Extension
1st Mar 20214:41 pmRNSSecond Price Monitoring Extn
1st Mar 20214:36 pmRNSPrice Monitoring Extension
26th Feb 20212:06 pmRNSSecond Price Monitoring Extn
26th Feb 20212:00 pmRNSPrice Monitoring Extension
26th Feb 20217:00 amRNSEquity Fundraise Update
19th Feb 20217:00 amRNS£3.5 million Equity Fundraise
15th Feb 20212:00 pmRNSTermination of DTU Acquisition
3rd Dec 20209:44 amRNSSubscription for £55,000 of Convertible Loan Stock
5th Nov 20207:00 amRNSFurther re the Acquisition of 75% of DT Ultravert
8th Oct 20209:55 amRNSOption Surrender and Issue of Replacement Options
5th Oct 20207:00 amRNSProposed sale of Kansas Land Leases and equipment
1st Oct 202011:41 amRNSFurther re the Acquisition of DT Ultravert
30th Sep 20207:00 amRNSBoard Changes & Acquisition of Deferred Shares
10th Sep 20201:30 pmRNSInterim Results for the six months to 30 June 2020
10th Sep 20201:15 pmRNSFinal Results for the Year Ended 31 December 2019

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.